The Europe Parenteral Nutrition Market is expected to witness market growth of 7.7% CAGR during the forecast period (2021-2027).
Parenteral nutrition can be administered to children as well as infants that need special nutritional management because of a disease or medical condition. Specialized Nutrition Europe (SNE) reports that approximately 300,000 children in the EU are likely to need medical nutrition for some medical purposes during the developmental phases of their life so as to promote healthy growth and development. It also notes that approximately two-fifth of the adult patients in hospitals are malnourished and need medical nutrition with an aim to better manage the malnutrition related to disease, which is expected to lower down the duration of hospital stay.
The European parenteral nutrition market is expected to be boosted by the governments of different countries of this region is undertaking various initiatives like the national initiative of Germany with an aim to promote nutritional awareness. The consumers residing in the region are highly adopting parenteral nutrition in order to treat insufficiency of nutrition and other required elements. Thus, the regional population prefers this method significantly due to its various benefits.
In 2020, the European Society for Clinical Nutrition and Metabolism formulated the regulations regarding the nutritional management of individuals infected with the coronavirus. According to the article circulated in 2020, the coronavirus led to a significant absence of appetite along with other symptoms that result in loss of muscle mass and a weakening immune response. To tackle this situation, clinics and hospitals have increased the accessibility of healthcare facilities for patients that need nutrition based on the disease. These developments are anticipated to boost the demand & adoption of intravenous administration of nutrition in patients.
The Germany market dominated the Europe Carbohydrates Market by Country in 2020, thereby, achieving a market value of $168 million by 2027. The UK market is experiencing a CAGR of 7.3% during (2021 - 2027). Additionally, The France market is anticipated to witness a CAGR of 9.7% during (2021 - 2027).
Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.
Scope of the Study
Market Segments Covered in the Report:
By Nutrient Type
- Single Dose Amino Acid Solution
- Parenteral Lipid Emulsion
- Carbohydrates
- Trace Elements,
- Vitamins & Minerals
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B.Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Methodology
LOADING...
